As the demand for COVID vaccines decreases worldwide, Moderna is planning to release a RSV vaccine, pending U.S. approval.
Moderna posted a narrower-than-expected loss for the first quarter as the company's cost-cutting efforts took hold and sales ...
News that the Biden administration is planning to push for Americans to get the updated COVID vaccines this fall caused several vaccine manufacturers' stock prices to rise Monday. Moderna CEO ...
AstraZeneca Plc pulled its Covid-19 vaccine from the market due to lack of demand for a shot that initially raised hopes it would play a key role in protecting the world against the virus.
A guide to the coronavirus vaccination rollout and what you need to know about the authorized vaccines Some 63.8% of Americans have received both doses of the two-shot Pfizer-BioNTech and Moderna ...
Authors focused their research on those who received the COVID vaccine from Pfizer or Moderna and died within 100 days of receiving their shots. Only 40 deaths occurred in that window. Of the 40 ...
Shah Capital’s decision to launch an activist campaign against Novavax comes as the shares of more successful Covid-19 vaccine makers such as Pfizer, BioNTech and Moderna have fallen as pandemic ...
The US Food and Drug Administration (FDA) approved the latest versions of COVID-19 ... updated vaccines will be critical to protecting the population this season,” Moderna CEO Stéphane Bancel ...
Jamie Scott was left with a permanent brain injury after having a haemorrhage the day after the Covid vaccine Credit: Andrew Fox AstraZeneca has admitted for the first time in court documents that ...
WATCH: Nobel in medicine goes to scientists whose work on mRNA led to COVID vaccine Hungarian-American Katalin Karikó and American Drew Weissman were cited for contributing vaccine development ...